Association of Clinical Trials Organizations (ACTO) Newsletter No. 7
Moscow 2013
The Association of Clinical Trials Organizations (ACTO) presented newsletter No. 7 with results from the first half of 2013 detailing the state of clinical trials in Russia.
During the first half of 2013, the Russian Ministry of Health issued 404 approvals for conducting clinical trials, down 10% from the same time last year. The number of international trials is also down 14.1% from last year, as is the number of bioequivalence studies, which is down 20.7%.
You can read the full report, including analysis of these numbers and thoughts on possible causes, (PDF) here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA to Launch National Priority Voucher Program to Speed Drug Reviews for Critical Therapies
June 18th 2025Under the new initiative, companies may receive a voucher enabling FDA review to be shortened from the standard 10–12 months to just 1–2 months following final application submission if the drug addresses US national health priorities.
